scholarly journals A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer

2013 ◽  
Vol 134 (4) ◽  
pp. 939-947 ◽  
Author(s):  
David Mesher ◽  
Isis Dove-Edwin ◽  
Peter Sasieni ◽  
Hans Vasen ◽  
Inge Bernstein ◽  
...  
2015 ◽  
Vol 33 (35) ◽  
pp. 4188-4193 ◽  
Author(s):  
Simone D. Hennink ◽  
Andrea E. van der Meulen-de Jong ◽  
Ron Wolterbeek ◽  
A. Stijn L.P. Crobach ◽  
Marco C.J.M. Becx ◽  
...  

Purpose Colonoscopic surveillance is recommended for individuals with familial colorectal cancer (CRC). However, the appropriate screening interval has not yet been determined. The aim of this randomized trial was to compare a 3-year with a 6-year screening interval. Patients and Methods Individuals between ages 45 and 65 years with one first-degree relative with CRC age < 50 years or two first-degree relatives with CRC were selected. Patients with zero to two adenomas at baseline were randomly assigned to one of two groups: group A (colonoscopy at 6 years) or group B (colonoscopy at 3 and 6 years). The primary outcome measure was advanced adenomatous polyps (AAPs). Risk factors studied included sex, age, type of family history, and baseline endoscopic findings. Results A total of 528 patients were randomly assigned (group A, n = 262; group B, n = 266). Intention-to-treat analysis showed no significant difference in the proportion of patients with AAPs at the first follow-up examination at 6 years in group A (6.9%) versus 3 years in group B (3.5%). Also, the proportion of patients with AAPs at the final follow-up examination at 6 years in group A (6.9%) versus 6 years in group B (3.4%) was not significantly different. Only AAPs at baseline was a significant predictor for the presence of AAPs at first follow-up. After correction for the difference in AAPs at baseline, differences between the groups in the rate of AAPs at first follow-up and at the final examination were statistically significant. Conclusion In view of the relatively low rate of AAPs at 6 years and the absence of CRC in group A, we consider a 6-year surveillance interval appropriate. A surveillance interval of 3 years might be considered in patients with AAPs and patients with ≥ three adenomas.


2001 ◽  
Vol 120 (5) ◽  
pp. A742
Author(s):  
Isis Dove-Edwin ◽  
Christopher B. Williams ◽  
Peter Sasieni ◽  
Huw Jw Thomas

2018 ◽  
Author(s):  
L Adán Merino ◽  
M Aldeguer Martínez ◽  
F Valentín Gómez ◽  
J Barrio Antoranz ◽  
R Plaza Santos ◽  
...  

2015 ◽  
Vol 41 (6) ◽  
pp. 573-580 ◽  
Author(s):  
N. J. Samadder ◽  
K. R. Smith ◽  
G. P. Mineau ◽  
R. Pimentel ◽  
J. Wong ◽  
...  

2015 ◽  
Vol 45 (5) ◽  
pp. 482-491 ◽  
Author(s):  
M. S. Lung ◽  
A. H. Trainer ◽  
I. Campbell ◽  
L. Lipton

Sign in / Sign up

Export Citation Format

Share Document